Caspase-7, Fas and FasL in long-term renal ischaemia/reperfusion and immunosuppressive injuries in rats

American Journal of Nephrology

Volumn 27, Issue 4, 2007, Pages 397-408

  Yang, Bin ^a   Harris, Kevin P G ^a   Jain, Sunjay ^a   Nicholson, Michael L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Caspase 7; Fas; FasL; Immunosuppression; Inflammation; Ischaemia reperfusion injury

Indexed keywords

CASPASE 3; CASPASE 7; CYCLOSPORIN A; FAS ANTIGEN; FAS LIGAND; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; INFLAMMATION; KIDNEY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY STRUCTURE; KIDNEY TUBULE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 7; FAS LIGAND PROTEIN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS; RATS; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 34447576715     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104741     Document Type: Article

References (33)

1. Gueler F, Gwinner W, Schwarz A, Haller H: Long-term effects of acute ischemia and reperfusion injury. Kidney Int 2004;66:523-527.
2. Yang B, Jain S, Pawluczyk IZ, Imtiaz S, Bowley L, Ashra SY, Nicholson ML: Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney Int 2005;68:2050-2067.
3. Daemen MA, de Vries B, Buurman WA: Apoptosis and inflammation in renal reperfusion injury. Transplantation 2002;73:1693-1700.
4. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C: Vital functions for lethal caspases. Oncogene 2005;24:5137-5148.
5. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 2001;107:1145-1152.
6. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL: Neutrophil-independent mechanisms of caspase-1-and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 2002;110:1083-1091.
7. Chatterjee PK, Todorovic Z, Sivarajah A, Mota-Filipe H, Brown PA, Stewart KN, Cuzzocrea S, Thiemermann C: Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney. Eur J Pharmacol 2004;503:173-183.
8. Yang B, El Nahas AM, Fisher M, Wagner B, Huang L, Storie I, Barnett D, Barratt J, Smith AC, Johnson TS: Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis. Nephron Exp Nephrol 2004;96:e39-e51.
9. Daemen MA, Denecker G, van't Veer C, Wolfs TG, Vandenabeele P, Buurman WA: Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion. Transplantation 2001;71:778-784.
10. Behrensdorf HA, van de Craen M, Knies UE, Vandenabeele P, Clauss M: The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett 2000;466:143-147.
11. Wei Y, Fox T, Chambers SP, Sintchak J, Coll JT, Golec JM, Swenson L, Wilson KP, Charifson PS: The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 2000;7:423-432.
12. Jo SK, Yun SY, Chang KH, DR, Cho WY, Kim HK, Won NH: alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 2001;16:1583-1591.
13. Ortiz A, Justo P, Catalan MP, Sanz AB, Lorz C, Egido J: Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2002;2:181-192.
14. Jain S, Bicknell GR, Nicholson ML: Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg 2000;87:1563-1568.
15. Yang B, Jain S, Ashra SY, Furness PN, Nicholson ML: Apoptosis and caspase-3 in longterm renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation 2006;81:1442-1450.
16. Little SA, Kim WK, Mirkes PE: Teratogen-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos. Cell Biol Toxicol 2003;19:215-226.
17. Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T, Yoshida J: Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells. J Neurooncol 2004;67:273-280.
18. Sung YH, Hwang SJ, Lee GM: Influence of down-regulation of caspase-3 by siRNAs on sodium-butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng 2005;7:457-466.
19. Puig B, Tortosa A, Ferrer I: Cleaved caspase-3, caspase-7 and poly (ADP-ribose) polymerase are complementarily but differentially expressed in human medulloblastomas. Neurosci Lett 2001;306:85-88.
20. Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA: Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 2002;99:15188-15193.
21. Liang Y, Yan C, Schor NF: Apoptosis in the absence of caspase 3. Oncogene 2001;20:6570-6578.
22. de Vries B, Matthijsen RA, van Bijnen AA, Wolfs TG, Buurman WA: Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 2003;163:47-56.
23. Yang B, Johnson TS, Haylor JL, Wagner B, Watson PF, El Kossi MM, Furness PN, El Nahas AM: Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int 2003;63:2050-2064.
24. Hortelano S, Castilla M, Torres AM, Tejedor A, Bosca L: Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol 2000;11:2315-2323.
25. Shihab FS, Andoh TF, Tanner AM, Yi H, Bennett WM: Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int 2000;56:2147-2159.
26. Hortelano S, Lopez-Collazo E, Bosca L: Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages. Br J Pharmacol 1999;126:1139-1146.
27. Yang CW, Ahn HJ, Han HJ, Kim WY, Li C, Shin MJ, Kim SK, Park JH, Kim YS, Moon IS, Bang BK: Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 2001;72:1753-1759.
28. Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS: Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001;281:F693-F706.
29. Mercalli A, Sordi V, Ponzoni M, Maffi P, De Taddeo F, Gatti G, Servida P, Bernardi M, Bellio L, Bertuzzi F, Secchi A, Bonifacio E, Piemonti L: Rapamycin induces a caspase-independent cell death in human monocytes. Am J Transplant 2006;6:1331-1341.
30. Eugui EM, Almquist SJ, Muller CD, Allison AC: Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991;33:161-173.
31. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M: Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000;58:51-61.
32. Schelling JR, Nkemere N, Kopp JB, Cleveland RP: Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998;78:813-824.
33. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 2004;101:14883-14888.